nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A1—liver cancer	0.519	1	CbGaD
Riluzole—ABCG2—Sorafenib—liver cancer	0.0995	0.495	CbGbCtD
Riluzole—ABCG2—Doxorubicin—liver cancer	0.0604	0.3	CbGbCtD
Riluzole—CYP1A2—Sorafenib—liver cancer	0.041	0.204	CbGbCtD
Riluzole—Hypokalaemia—Epirubicin—liver cancer	0.000212	0.00108	CcSEcCtD
Riluzole—Diarrhoea—Sorafenib—liver cancer	0.000212	0.00108	CcSEcCtD
Riluzole—Breast disorder—Epirubicin—liver cancer	0.00021	0.00108	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00021	0.00107	CcSEcCtD
Riluzole—Face oedema—Doxorubicin—liver cancer	0.000208	0.00106	CcSEcCtD
Riluzole—Gastritis—Epirubicin—liver cancer	0.000206	0.00105	CcSEcCtD
Riluzole—Muscular weakness—Epirubicin—liver cancer	0.000205	0.00105	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000205	0.00105	CcSEcCtD
Riluzole—Cardiac arrest—Doxorubicin—liver cancer	0.000205	0.00105	CcSEcCtD
Riluzole—Dizziness—Sorafenib—liver cancer	0.000205	0.00105	CcSEcCtD
Riluzole—Mood swings—Doxorubicin—liver cancer	0.000204	0.00104	CcSEcCtD
Riluzole—Abdominal distension—Epirubicin—liver cancer	0.000203	0.00104	CcSEcCtD
Riluzole—Ataxia—Doxorubicin—liver cancer	0.000203	0.00104	CcSEcCtD
Riluzole—Dysphagia—Epirubicin—liver cancer	0.000201	0.00103	CcSEcCtD
Riluzole—Asthma—Epirubicin—liver cancer	0.000201	0.00103	CcSEcCtD
Riluzole—Influenza—Epirubicin—liver cancer	0.000201	0.00103	CcSEcCtD
Riluzole—Dehydration—Doxorubicin—liver cancer	0.0002	0.00103	CcSEcCtD
Riluzole—Liver function test abnormal—Doxorubicin—liver cancer	0.000199	0.00102	CcSEcCtD
Riluzole—Pancreatitis—Epirubicin—liver cancer	0.000197	0.00101	CcSEcCtD
Riluzole—Vomiting—Sorafenib—liver cancer	0.000197	0.00101	CcSEcCtD
Riluzole—Orthostatic hypotension—Doxorubicin—liver cancer	0.000197	0.00101	CcSEcCtD
Riluzole—Hypokalaemia—Doxorubicin—liver cancer	0.000196	0.001	CcSEcCtD
Riluzole—Angina pectoris—Epirubicin—liver cancer	0.000196	0.001	CcSEcCtD
Riluzole—Rash—Sorafenib—liver cancer	0.000195	0.000999	CcSEcCtD
Riluzole—Dermatitis—Sorafenib—liver cancer	0.000195	0.000999	CcSEcCtD
Riluzole—Breast disorder—Doxorubicin—liver cancer	0.000195	0.000997	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000194	0.000993	CcSEcCtD
Riluzole—Headache—Sorafenib—liver cancer	0.000194	0.000993	CcSEcCtD
Riluzole—Bronchitis—Epirubicin—liver cancer	0.000193	0.000991	CcSEcCtD
Riluzole—Pancytopenia—Epirubicin—liver cancer	0.000191	0.000978	CcSEcCtD
Riluzole—Gastritis—Doxorubicin—liver cancer	0.000191	0.000976	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00019	0.000973	CcSEcCtD
Riluzole—Muscular weakness—Doxorubicin—liver cancer	0.00019	0.000973	CcSEcCtD
Riluzole—Dysuria—Epirubicin—liver cancer	0.000188	0.000963	CcSEcCtD
Riluzole—Neutropenia—Epirubicin—liver cancer	0.000188	0.000963	CcSEcCtD
Riluzole—Abdominal distension—Doxorubicin—liver cancer	0.000187	0.00096	CcSEcCtD
Riluzole—Asthma—Doxorubicin—liver cancer	0.000186	0.000953	CcSEcCtD
Riluzole—Influenza—Doxorubicin—liver cancer	0.000186	0.000953	CcSEcCtD
Riluzole—Dysphagia—Doxorubicin—liver cancer	0.000186	0.000953	CcSEcCtD
Riluzole—Pollakiuria—Epirubicin—liver cancer	0.000186	0.000952	CcSEcCtD
Riluzole—Nausea—Sorafenib—liver cancer	0.000184	0.000942	CcSEcCtD
Riluzole—Photosensitivity reaction—Epirubicin—liver cancer	0.000184	0.00094	CcSEcCtD
Riluzole—Weight increased—Epirubicin—liver cancer	0.000183	0.000938	CcSEcCtD
Riluzole—Pancreatitis—Doxorubicin—liver cancer	0.000183	0.000935	CcSEcCtD
Riluzole—Weight decreased—Epirubicin—liver cancer	0.000182	0.000932	CcSEcCtD
Riluzole—Angina pectoris—Doxorubicin—liver cancer	0.000181	0.000929	CcSEcCtD
Riluzole—Pneumonia—Epirubicin—liver cancer	0.00018	0.000924	CcSEcCtD
Riluzole—Infestation NOS—Epirubicin—liver cancer	0.000179	0.000919	CcSEcCtD
Riluzole—Infestation—Epirubicin—liver cancer	0.000179	0.000919	CcSEcCtD
Riluzole—Bronchitis—Doxorubicin—liver cancer	0.000179	0.000917	CcSEcCtD
Riluzole—Pancytopenia—Doxorubicin—liver cancer	0.000177	0.000905	CcSEcCtD
Riluzole—Neuropathy peripheral—Epirubicin—liver cancer	0.000176	0.0009	CcSEcCtD
Riluzole—Jaundice—Epirubicin—liver cancer	0.000175	0.000895	CcSEcCtD
Riluzole—Stomatitis—Epirubicin—liver cancer	0.000175	0.000895	CcSEcCtD
Riluzole—Urinary tract infection—Epirubicin—liver cancer	0.000174	0.000893	CcSEcCtD
Riluzole—Neutropenia—Doxorubicin—liver cancer	0.000174	0.000891	CcSEcCtD
Riluzole—Dysuria—Doxorubicin—liver cancer	0.000174	0.000891	CcSEcCtD
Riluzole—Sweating—Epirubicin—liver cancer	0.000172	0.000881	CcSEcCtD
Riluzole—Pollakiuria—Doxorubicin—liver cancer	0.000172	0.000881	CcSEcCtD
Riluzole—Haematuria—Epirubicin—liver cancer	0.000171	0.000876	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—liver cancer	0.00017	0.00087	CcSEcCtD
Riluzole—Hepatobiliary disease—Epirubicin—liver cancer	0.00017	0.000869	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—liver cancer	0.000169	0.000867	CcSEcCtD
Riluzole—Epistaxis—Epirubicin—liver cancer	0.000169	0.000866	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—liver cancer	0.000168	0.000862	CcSEcCtD
Riluzole—Sinusitis—Epirubicin—liver cancer	0.000168	0.000862	CcSEcCtD
Riluzole—Agranulocytosis—Epirubicin—liver cancer	0.000167	0.000857	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—liver cancer	0.000167	0.000855	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—liver cancer	0.000166	0.00085	CcSEcCtD
Riluzole—Infestation—Doxorubicin—liver cancer	0.000166	0.00085	CcSEcCtD
Riluzole—Bradycardia—Epirubicin—liver cancer	0.000164	0.000839	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—liver cancer	0.000163	0.000833	CcSEcCtD
Riluzole—Haemoglobin—Epirubicin—liver cancer	0.000162	0.000829	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—liver cancer	0.000162	0.000828	CcSEcCtD
Riluzole—Jaundice—Doxorubicin—liver cancer	0.000162	0.000828	CcSEcCtD
Riluzole—Rhinitis—Epirubicin—liver cancer	0.000161	0.000827	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—liver cancer	0.000161	0.000826	CcSEcCtD
Riluzole—Hepatitis—Epirubicin—liver cancer	0.000161	0.000825	CcSEcCtD
Riluzole—Haemorrhage—Epirubicin—liver cancer	0.000161	0.000825	CcSEcCtD
Riluzole—Hypoaesthesia—Epirubicin—liver cancer	0.00016	0.00082	CcSEcCtD
Riluzole—Pharyngitis—Epirubicin—liver cancer	0.00016	0.000818	CcSEcCtD
Riluzole—Sweating—Doxorubicin—liver cancer	0.000159	0.000815	CcSEcCtD
Riluzole—Urinary tract disorder—Epirubicin—liver cancer	0.000159	0.000814	CcSEcCtD
Riluzole—Oedema peripheral—Epirubicin—liver cancer	0.000159	0.000812	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—liver cancer	0.000158	0.00081	CcSEcCtD
Riluzole—Connective tissue disorder—Epirubicin—liver cancer	0.000158	0.00081	CcSEcCtD
Riluzole—Urethral disorder—Epirubicin—liver cancer	0.000158	0.000808	CcSEcCtD
Riluzole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000157	0.000804	CcSEcCtD
Riluzole—Epistaxis—Doxorubicin—liver cancer	0.000157	0.000802	CcSEcCtD
Riluzole—Sinusitis—Doxorubicin—liver cancer	0.000156	0.000797	CcSEcCtD
Riluzole—Agranulocytosis—Doxorubicin—liver cancer	0.000155	0.000793	CcSEcCtD
Riluzole—Erythema multiforme—Epirubicin—liver cancer	0.000152	0.00078	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—liver cancer	0.000152	0.000777	CcSEcCtD
Riluzole—Eye disorder—Epirubicin—liver cancer	0.00015	0.000771	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—liver cancer	0.00015	0.000767	CcSEcCtD
Riluzole—Cardiac disorder—Epirubicin—liver cancer	0.000149	0.000765	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—liver cancer	0.000149	0.000765	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—liver cancer	0.000149	0.000763	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—liver cancer	0.000149	0.000763	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—liver cancer	0.000148	0.000759	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—liver cancer	0.000148	0.000757	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—liver cancer	0.000147	0.000753	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—liver cancer	0.000147	0.000752	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—liver cancer	0.000146	0.00075	CcSEcCtD
Riluzole—Angiopathy—Epirubicin—liver cancer	0.000146	0.000748	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—liver cancer	0.000146	0.000748	CcSEcCtD
Riluzole—Immune system disorder—Epirubicin—liver cancer	0.000145	0.000745	CcSEcCtD
Riluzole—Mediastinal disorder—Epirubicin—liver cancer	0.000145	0.000743	CcSEcCtD
Riluzole—Chills—Epirubicin—liver cancer	0.000144	0.00074	CcSEcCtD
Riluzole—Arrhythmia—Epirubicin—liver cancer	0.000144	0.000737	CcSEcCtD
Riluzole—Alopecia—Epirubicin—liver cancer	0.000142	0.000729	CcSEcCtD
Riluzole—Mental disorder—Epirubicin—liver cancer	0.000141	0.000722	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—liver cancer	0.000141	0.000721	CcSEcCtD
Riluzole—Malnutrition—Epirubicin—liver cancer	0.00014	0.000718	CcSEcCtD
Riluzole—Eye disorder—Doxorubicin—liver cancer	0.000139	0.000713	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—liver cancer	0.000138	0.000708	CcSEcCtD
Riluzole—Flatulence—Epirubicin—liver cancer	0.000138	0.000707	CcSEcCtD
Riluzole—Tension—Epirubicin—liver cancer	0.000138	0.000704	CcSEcCtD
Riluzole—Dysgeusia—Epirubicin—liver cancer	0.000137	0.000703	CcSEcCtD
Riluzole—Nervousness—Epirubicin—liver cancer	0.000136	0.000697	CcSEcCtD
Riluzole—Back pain—Epirubicin—liver cancer	0.000136	0.000694	CcSEcCtD
Riluzole—Angiopathy—Doxorubicin—liver cancer	0.000135	0.000692	CcSEcCtD
Riluzole—Muscle spasms—Epirubicin—liver cancer	0.000135	0.00069	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—liver cancer	0.000135	0.000689	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—liver cancer	0.000134	0.000688	CcSEcCtD
Riluzole—Chills—Doxorubicin—liver cancer	0.000134	0.000685	CcSEcCtD
Riluzole—Arrhythmia—Doxorubicin—liver cancer	0.000133	0.000682	CcSEcCtD
Riluzole—Alopecia—Doxorubicin—liver cancer	0.000132	0.000674	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—liver cancer	0.000131	0.000668	CcSEcCtD
Riluzole—Ill-defined disorder—Epirubicin—liver cancer	0.00013	0.000666	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—liver cancer	0.00013	0.000664	CcSEcCtD
Riluzole—Anaemia—Epirubicin—liver cancer	0.00013	0.000663	CcSEcCtD
Riluzole—Agitation—Epirubicin—liver cancer	0.000129	0.00066	CcSEcCtD
Riluzole—Flatulence—Doxorubicin—liver cancer	0.000128	0.000654	CcSEcCtD
Riluzole—Tension—Doxorubicin—liver cancer	0.000127	0.000652	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—liver cancer	0.000127	0.00065	CcSEcCtD
Riluzole—Malaise—Epirubicin—liver cancer	0.000126	0.000647	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—liver cancer	0.000126	0.000645	CcSEcCtD
Riluzole—Vertigo—Epirubicin—liver cancer	0.000126	0.000645	CcSEcCtD
Riluzole—Syncope—Epirubicin—liver cancer	0.000126	0.000644	CcSEcCtD
Riluzole—Leukopenia—Epirubicin—liver cancer	0.000125	0.000643	CcSEcCtD
Riluzole—Back pain—Doxorubicin—liver cancer	0.000125	0.000642	CcSEcCtD
Riluzole—Muscle spasms—Doxorubicin—liver cancer	0.000125	0.000639	CcSEcCtD
Riluzole—Palpitations—Epirubicin—liver cancer	0.000124	0.000634	CcSEcCtD
Riluzole—Loss of consciousness—Epirubicin—liver cancer	0.000123	0.000631	CcSEcCtD
Riluzole—Cough—Epirubicin—liver cancer	0.000122	0.000626	CcSEcCtD
Riluzole—Convulsion—Epirubicin—liver cancer	0.000121	0.000622	CcSEcCtD
Riluzole—Hypertension—Epirubicin—liver cancer	0.000121	0.00062	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—liver cancer	0.00012	0.000616	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—liver cancer	0.00012	0.000614	CcSEcCtD
Riluzole—Myalgia—Epirubicin—liver cancer	0.000119	0.000611	CcSEcCtD
Riluzole—Chest pain—Epirubicin—liver cancer	0.000119	0.000611	CcSEcCtD
Riluzole—Arthralgia—Epirubicin—liver cancer	0.000119	0.000611	CcSEcCtD
Riluzole—Agitation—Doxorubicin—liver cancer	0.000119	0.00061	CcSEcCtD
Riluzole—Anxiety—Epirubicin—liver cancer	0.000119	0.000609	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000119	0.000607	CcSEcCtD
Riluzole—Discomfort—Epirubicin—liver cancer	0.000118	0.000604	CcSEcCtD
Riluzole—Malaise—Doxorubicin—liver cancer	0.000117	0.000599	CcSEcCtD
Riluzole—Dry mouth—Epirubicin—liver cancer	0.000117	0.000598	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000117	0.00137	CbGpPWpGaD
Riluzole—Vertigo—Doxorubicin—liver cancer	0.000117	0.000597	CcSEcCtD
Riluzole—Syncope—Doxorubicin—liver cancer	0.000116	0.000596	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—liver cancer	0.000116	0.000595	CcSEcCtD
Riluzole—Confusional state—Epirubicin—liver cancer	0.000115	0.000591	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—liver cancer	0.000115	0.000587	CcSEcCtD
Riluzole—Oedema—Epirubicin—liver cancer	0.000114	0.000586	CcSEcCtD
Riluzole—Anaphylactic shock—Epirubicin—liver cancer	0.000114	0.000586	CcSEcCtD
Riluzole—Loss of consciousness—Doxorubicin—liver cancer	0.000114	0.000584	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	0.000114	0.00134	CbGpPWpGaD
Riluzole—Infection—Epirubicin—liver cancer	0.000114	0.000582	CcSEcCtD
Riluzole—Cough—Doxorubicin—liver cancer	0.000113	0.00058	CcSEcCtD
Riluzole—Shock—Epirubicin—liver cancer	0.000113	0.000576	CcSEcCtD
Riluzole—Convulsion—Doxorubicin—liver cancer	0.000112	0.000575	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000112	0.00132	CbGpPWpGaD
Riluzole—Nervous system disorder—Epirubicin—liver cancer	0.000112	0.000574	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.000112	0.00132	CbGpPWpGaD
Riluzole—Thrombocytopenia—Epirubicin—liver cancer	0.000112	0.000574	CcSEcCtD
Riluzole—Hypertension—Doxorubicin—liver cancer	0.000112	0.000573	CcSEcCtD
Riluzole—Tachycardia—Epirubicin—liver cancer	0.000112	0.000572	CcSEcCtD
Riluzole—Skin disorder—Epirubicin—liver cancer	0.000111	0.000569	CcSEcCtD
Riluzole—Hyperhidrosis—Epirubicin—liver cancer	0.000111	0.000566	CcSEcCtD
Riluzole—Myalgia—Doxorubicin—liver cancer	0.00011	0.000565	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—liver cancer	0.00011	0.000565	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—liver cancer	0.00011	0.000565	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.00011	0.0013	CbGpPWpGaD
Riluzole—Anxiety—Doxorubicin—liver cancer	0.00011	0.000563	CcSEcCtD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.00011	0.00129	CbGpPWpGaD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00011	0.000562	CcSEcCtD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000109	0.00129	CbGpPWpGaD
Riluzole—Discomfort—Doxorubicin—liver cancer	0.000109	0.000559	CcSEcCtD
Riluzole—Anorexia—Epirubicin—liver cancer	0.000109	0.000558	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTA4—liver cancer	0.000108	0.00127	CbGpPWpGaD
Riluzole—Dry mouth—Doxorubicin—liver cancer	0.000108	0.000553	CcSEcCtD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000108	0.00127	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000108	0.00127	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000108	0.00127	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—MAPK14—liver cancer	0.000107	0.00126	CbGpPWpGaD
Riluzole—Hypotension—Epirubicin—liver cancer	0.000107	0.000547	CcSEcCtD
Riluzole—Confusional state—Doxorubicin—liver cancer	0.000107	0.000547	CcSEcCtD
Riluzole—CYP1A2—Metapathway biotransformation—GSTA4—liver cancer	0.000107	0.00126	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000107	0.00125	CbGpPWpGaD
Riluzole—Oedema—Doxorubicin—liver cancer	0.000106	0.000542	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—liver cancer	0.000106	0.000542	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTA2—liver cancer	0.000105	0.00124	CbGpPWpGaD
Riluzole—Infection—Doxorubicin—liver cancer	0.000105	0.000539	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000104	0.000534	CcSEcCtD
Riluzole—Shock—Doxorubicin—liver cancer	0.000104	0.000533	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—F2—liver cancer	0.000104	0.00122	CbGpPWpGaD
Riluzole—Nervous system disorder—Doxorubicin—liver cancer	0.000104	0.000532	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—liver cancer	0.000104	0.000531	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—JUN—liver cancer	0.000104	0.00122	CbGpPWpGaD
Riluzole—Insomnia—Epirubicin—liver cancer	0.000103	0.00053	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—liver cancer	0.000103	0.000529	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—GGT1—liver cancer	0.000103	0.00121	CbGpPWpGaD
Riluzole—Skin disorder—Doxorubicin—liver cancer	0.000103	0.000527	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—CYP2E1—liver cancer	0.000103	0.00121	CbGpPWpGaD
Riluzole—Paraesthesia—Epirubicin—liver cancer	0.000103	0.000526	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000103	0.00121	CbGpPWpGaD
Riluzole—Hyperhidrosis—Doxorubicin—liver cancer	0.000102	0.000524	CcSEcCtD
Riluzole—Dyspnoea—Epirubicin—liver cancer	0.000102	0.000522	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000102	0.0012	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTA1—liver cancer	0.000102	0.0012	CbGpPWpGaD
Riluzole—Somnolence—Epirubicin—liver cancer	0.000102	0.000521	CcSEcCtD
Riluzole—CYP1A1—Metapathway biotransformation—CYP2E1—liver cancer	0.000101	0.00119	CbGpPWpGaD
Riluzole—Anorexia—Doxorubicin—liver cancer	0.000101	0.000517	CcSEcCtD
Riluzole—Dyspepsia—Epirubicin—liver cancer	0.000101	0.000516	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—PPARA—liver cancer	0.000101	0.00118	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—NAT2—liver cancer	0.000101	0.00118	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CG—liver cancer	9.95e-05	0.00117	CbGpPWpGaD
Riluzole—Decreased appetite—Epirubicin—liver cancer	9.95e-05	0.000509	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	9.94e-05	0.00117	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—NAT2—liver cancer	9.92e-05	0.00117	CbGpPWpGaD
Riluzole—Hypotension—Doxorubicin—liver cancer	9.89e-05	0.000506	CcSEcCtD
Riluzole—Gastrointestinal disorder—Epirubicin—liver cancer	9.88e-05	0.000506	CcSEcCtD
Riluzole—Fatigue—Epirubicin—liver cancer	9.86e-05	0.000505	CcSEcCtD
Riluzole—Constipation—Epirubicin—liver cancer	9.78e-05	0.000501	CcSEcCtD
Riluzole—Pain—Epirubicin—liver cancer	9.78e-05	0.000501	CcSEcCtD
Riluzole—CYP1A1—PPARA activates gene expression—PPARA—liver cancer	9.66e-05	0.00114	CbGpPWpGaD
Riluzole—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.64e-05	0.000494	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—liver cancer	9.57e-05	0.00049	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—liver cancer	9.51e-05	0.000487	CcSEcCtD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—liver cancer	9.45e-05	0.00111	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GGT1—liver cancer	9.44e-05	0.00111	CbGpPWpGaD
Riluzole—Dyspnoea—Doxorubicin—liver cancer	9.44e-05	0.000483	CcSEcCtD
Riluzole—Feeling abnormal—Epirubicin—liver cancer	9.43e-05	0.000483	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—liver cancer	9.41e-05	0.000482	CcSEcCtD
Riluzole—Gastrointestinal pain—Epirubicin—liver cancer	9.36e-05	0.000479	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—liver cancer	9.32e-05	0.000477	CcSEcCtD
Riluzole—CYP1A2—Phase II conjugation—GSTP1—liver cancer	9.24e-05	0.00109	CbGpPWpGaD
Riluzole—Decreased appetite—Doxorubicin—liver cancer	9.2e-05	0.000471	CcSEcCtD
Riluzole—SCN5A—Axon guidance—KDR—liver cancer	9.15e-05	0.00108	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—liver cancer	9.14e-05	0.00108	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Doxorubicin—liver cancer	9.14e-05	0.000468	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—liver cancer	9.13e-05	0.000467	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	9.12e-05	0.00107	CbGpPWpGaD
Riluzole—Urticaria—Epirubicin—liver cancer	9.09e-05	0.000465	CcSEcCtD
Riluzole—Constipation—Doxorubicin—liver cancer	9.05e-05	0.000464	CcSEcCtD
Riluzole—Pain—Doxorubicin—liver cancer	9.05e-05	0.000464	CcSEcCtD
Riluzole—Body temperature increased—Epirubicin—liver cancer	9.04e-05	0.000463	CcSEcCtD
Riluzole—Abdominal pain—Epirubicin—liver cancer	9.04e-05	0.000463	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—VEGFA—liver cancer	9.04e-05	0.00106	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MET—liver cancer	8.95e-05	0.00105	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	8.87e-05	0.00104	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CD—liver cancer	8.75e-05	0.00103	CbGpPWpGaD
Riluzole—Feeling abnormal—Doxorubicin—liver cancer	8.72e-05	0.000447	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—liver cancer	8.66e-05	0.000443	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—SERPINE1—liver cancer	8.65e-05	0.00102	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—ALB—liver cancer	8.64e-05	0.00102	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—ABL1—liver cancer	8.61e-05	0.00101	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	8.52e-05	0.001	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—liver cancer	8.52e-05	0.001	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTM1—liver cancer	8.49e-05	0.000999	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTP1—liver cancer	8.48e-05	0.000997	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—liver cancer	8.45e-05	0.000994	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GPX3—liver cancer	8.44e-05	0.000992	CbGpPWpGaD
Riluzole—Hypersensitivity—Epirubicin—liver cancer	8.43e-05	0.000432	CcSEcCtD
Riluzole—Urticaria—Doxorubicin—liver cancer	8.41e-05	0.000431	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—liver cancer	8.37e-05	0.000428	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—liver cancer	8.37e-05	0.000428	CcSEcCtD
Riluzole—CYP1A1—Metapathway biotransformation—GSTP1—liver cancer	8.36e-05	0.000983	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	8.32e-05	0.000978	CbGpPWpGaD
Riluzole—Asthenia—Epirubicin—liver cancer	8.21e-05	0.00042	CcSEcCtD
Riluzole—ABCG2—Metabolism—UGDH—liver cancer	8.16e-05	0.00096	CbGpPWpGaD
Riluzole—Pruritus—Epirubicin—liver cancer	8.09e-05	0.000414	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—HPGDS—liver cancer	8.04e-05	0.000946	CbGpPWpGaD
Riluzole—CYP1A1—PPARA activates gene expression—PPARG—liver cancer	7.98e-05	0.000939	CbGpPWpGaD
Riluzole—Diarrhoea—Epirubicin—liver cancer	7.83e-05	0.000401	CcSEcCtD
Riluzole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—liver cancer	7.81e-05	0.000919	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—RAF1—liver cancer	7.81e-05	0.000919	CbGpPWpGaD
Riluzole—Hypersensitivity—Doxorubicin—liver cancer	7.8e-05	0.000399	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—GSTM1—liver cancer	7.79e-05	0.000916	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—TNF—liver cancer	7.75e-05	0.000911	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTM1—liver cancer	7.68e-05	0.000904	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—EPT1—liver cancer	7.67e-05	0.000902	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CB—liver cancer	7.63e-05	0.000897	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—liver cancer	7.62e-05	0.000896	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	7.62e-05	0.000896	CbGpPWpGaD
Riluzole—Asthenia—Doxorubicin—liver cancer	7.59e-05	0.000389	CcSEcCtD
Riluzole—Dizziness—Epirubicin—liver cancer	7.57e-05	0.000387	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	7.52e-05	0.000884	CbGpPWpGaD
Riluzole—Pruritus—Doxorubicin—liver cancer	7.49e-05	0.000383	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ALB—liver cancer	7.48e-05	0.000879	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP2—liver cancer	7.47e-05	0.000878	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—liver cancer	7.46e-05	0.000877	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	7.44e-05	0.000875	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—TAT—liver cancer	7.27e-05	0.000856	CbGpPWpGaD
Riluzole—Vomiting—Epirubicin—liver cancer	7.27e-05	0.000372	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—liver cancer	7.25e-05	0.000853	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	7.25e-05	0.000852	CbGpPWpGaD
Riluzole—Diarrhoea—Doxorubicin—liver cancer	7.24e-05	0.000371	CcSEcCtD
Riluzole—Rash—Epirubicin—liver cancer	7.21e-05	0.000369	CcSEcCtD
Riluzole—Dermatitis—Epirubicin—liver cancer	7.21e-05	0.000369	CcSEcCtD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—liver cancer	7.18e-05	0.000845	CbGpPWpGaD
Riluzole—Headache—Epirubicin—liver cancer	7.17e-05	0.000367	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	7.03e-05	0.000827	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARA—liver cancer	7.02e-05	0.000826	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—AKT1—liver cancer	7.02e-05	0.000825	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IL2—liver cancer	7e-05	0.000824	CbGpPWpGaD
Riluzole—Dizziness—Doxorubicin—liver cancer	7e-05	0.000358	CcSEcCtD
Riluzole—Nausea—Epirubicin—liver cancer	6.8e-05	0.000348	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RAF1—liver cancer	6.76e-05	0.000795	CbGpPWpGaD
Riluzole—Vomiting—Doxorubicin—liver cancer	6.73e-05	0.000345	CcSEcCtD
Riluzole—Rash—Doxorubicin—liver cancer	6.67e-05	0.000342	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—liver cancer	6.67e-05	0.000341	CcSEcCtD
Riluzole—Headache—Doxorubicin—liver cancer	6.63e-05	0.00034	CcSEcCtD
Riluzole—SCN5A—Axon guidance—RAF1—liver cancer	6.61e-05	0.000778	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP2E1—liver cancer	6.56e-05	0.000771	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KDR—liver cancer	6.53e-05	0.000768	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—liver cancer	6.51e-05	0.000766	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MAPK14—liver cancer	6.48e-05	0.000763	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP2E1—liver cancer	6.47e-05	0.00076	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MET—liver cancer	6.39e-05	0.000751	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	6.34e-05	0.000745	CbGpPWpGaD
Riluzole—Nausea—Doxorubicin—liver cancer	6.29e-05	0.000322	CcSEcCtD
Riluzole—SCN5A—SIDS Susceptibility Pathways—IL6—liver cancer	6.25e-05	0.000735	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GGT1—liver cancer	6.02e-05	0.000708	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—VEGFA—liver cancer	5.95e-05	0.0007	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	5.83e-05	0.000686	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	5.82e-05	0.000684	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PPARG—liver cancer	5.8e-05	0.000682	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MMP9—liver cancer	5.61e-05	0.00066	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	5.54e-05	0.000652	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—UGDH—liver cancer	5.52e-05	0.00065	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TGFB1—liver cancer	5.46e-05	0.000643	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	5.43e-05	0.000639	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	5.43e-05	0.000639	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTP1—liver cancer	5.41e-05	0.000636	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	5.39e-05	0.000634	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—liver cancer	5.38e-05	0.000633	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	5.33e-05	0.000627	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP2—liver cancer	5.33e-05	0.000627	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—EPT1—liver cancer	5.19e-05	0.000611	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—CYCS—liver cancer	5.19e-05	0.00061	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—KRAS—liver cancer	5.06e-05	0.000595	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—liver cancer	5.04e-05	0.000593	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—GSTM1—liver cancer	4.97e-05	0.000584	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CPT1B—liver cancer	4.94e-05	0.000582	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GLUL—liver cancer	4.94e-05	0.000582	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—TAT—liver cancer	4.92e-05	0.000579	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	4.9e-05	0.000576	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	4.84e-05	0.00057	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	4.79e-05	0.000564	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NR1H4—liver cancer	4.77e-05	0.000561	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RAF1—liver cancer	4.72e-05	0.000555	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—CYP1A1—liver cancer	4.71e-05	0.000554	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA3—liver cancer	4.69e-05	0.000551	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—PIK3CA—liver cancer	4.65e-05	0.000547	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	4.65e-05	0.000546	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	4.62e-05	0.000543	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	4.58e-05	0.000539	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—HMOX1—liver cancer	4.51e-05	0.00053	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—liver cancer	4.5e-05	0.000529	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—HRAS—liver cancer	4.3e-05	0.000506	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA4—liver cancer	4.29e-05	0.000504	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KRAS—liver cancer	4.28e-05	0.000504	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA2—liver cancer	4.18e-05	0.000491	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CTNNB1—liver cancer	4.08e-05	0.00048	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTA1—liver cancer	4.03e-05	0.000474	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MMP9—liver cancer	4e-05	0.000471	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—NAT2—liver cancer	3.99e-05	0.000469	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALDOB—liver cancer	3.82e-05	0.000449	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—AKT1—liver cancer	3.8e-05	0.000447	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CRABP1—liver cancer	3.65e-05	0.000429	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	3.64e-05	0.000429	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—HRAS—liver cancer	3.64e-05	0.000428	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.62e-05	0.000426	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—VEGFA—liver cancer	3.6e-05	0.000423	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—STAT3—liver cancer	3.56e-05	0.000419	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	3.53e-05	0.000415	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—UGDH—liver cancer	3.52e-05	0.000414	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—IL6—liver cancer	3.49e-05	0.00041	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GLUL—liver cancer	3.35e-05	0.000394	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CPT1B—liver cancer	3.35e-05	0.000394	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—EPT1—liver cancer	3.31e-05	0.00039	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TGFB1—liver cancer	3.3e-05	0.000388	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NR1H4—liver cancer	3.23e-05	0.00038	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HPGDS—liver cancer	3.19e-05	0.000375	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA3—liver cancer	3.17e-05	0.000373	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—TAT—liver cancer	3.14e-05	0.000369	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	3.09e-05	0.000363	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—TNF—liver cancer	3.08e-05	0.000362	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KRAS—liver cancer	3.06e-05	0.00036	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA4—liver cancer	2.9e-05	0.000341	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PSMD10—liver cancer	2.84e-05	0.000334	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PSMA4—liver cancer	2.84e-05	0.000334	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA2—liver cancer	2.83e-05	0.000333	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GOT2—liver cancer	2.76e-05	0.000325	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTA1—liver cancer	2.73e-05	0.000321	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	2.71e-05	0.000319	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—NAT2—liver cancer	2.7e-05	0.000317	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HRAS—liver cancer	2.6e-05	0.000306	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP2E1—liver cancer	2.6e-05	0.000305	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.59e-05	0.000305	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDOB—liver cancer	2.59e-05	0.000304	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—IL6—liver cancer	2.49e-05	0.000292	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CRABP1—liver cancer	2.47e-05	0.00029	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	2.45e-05	0.000288	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYCS—liver cancer	2.43e-05	0.000286	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GGT1—liver cancer	2.38e-05	0.00028	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GOT1—liver cancer	2.38e-05	0.00028	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.31e-05	0.000272	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—AKT1—liver cancer	2.29e-05	0.00027	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.22e-05	0.000261	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HPGDS—liver cancer	2.16e-05	0.000254	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.14e-05	0.000252	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—liver cancer	2.14e-05	0.000252	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CPT1B—liver cancer	2.13e-05	0.000251	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GLUL—liver cancer	2.13e-05	0.000251	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—HMOX1—liver cancer	2.11e-05	0.000248	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NR1H4—liver cancer	2.06e-05	0.000242	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA3—liver cancer	2.02e-05	0.000238	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—liver cancer	1.97e-05	0.000232	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.95e-05	0.00023	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.93e-05	0.000227	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PSMD10—liver cancer	1.92e-05	0.000226	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PSMA4—liver cancer	1.92e-05	0.000226	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GOT2—liver cancer	1.87e-05	0.00022	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP1A1—liver cancer	1.87e-05	0.000219	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA4—liver cancer	1.85e-05	0.000218	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.81e-05	0.000213	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA2—liver cancer	1.8e-05	0.000212	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYP2E1—liver cancer	1.76e-05	0.000207	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTA1—liver cancer	1.74e-05	0.000205	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—MTHFR—liver cancer	1.74e-05	0.000205	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—NAT2—liver cancer	1.72e-05	0.000202	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARA—liver cancer	1.71e-05	0.000201	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.7e-05	0.0002	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.65e-05	0.000195	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDOB—liver cancer	1.65e-05	0.000194	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CYCS—liver cancer	1.65e-05	0.000193	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GOT1—liver cancer	1.61e-05	0.00019	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GGT1—liver cancer	1.61e-05	0.00019	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CRABP1—liver cancer	1.57e-05	0.000185	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CG—liver cancer	1.46e-05	0.000172	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—liver cancer	1.45e-05	0.000171	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—HMOX1—liver cancer	1.43e-05	0.000168	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.42e-05	0.000167	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PPARG—liver cancer	1.41e-05	0.000166	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HPGDS—liver cancer	1.38e-05	0.000162	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.37e-05	0.000161	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—liver cancer	1.33e-05	0.000157	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CD—liver cancer	1.28e-05	0.000151	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALB—liver cancer	1.27e-05	0.000149	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.25e-05	0.000146	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.23e-05	0.000145	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PSMA4—liver cancer	1.23e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PSMD10—liver cancer	1.23e-05	0.000144	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GOT2—liver cancer	1.19e-05	0.00014	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—MTHFR—liver cancer	1.18e-05	0.000138	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARA—liver cancer	1.16e-05	0.000136	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP2E1—liver cancer	1.12e-05	0.000132	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CB—liver cancer	1.12e-05	0.000132	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.09e-05	0.000128	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYCS—liver cancer	1.05e-05	0.000123	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.04e-05	0.000122	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GOT1—liver cancer	1.03e-05	0.000121	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GGT1—liver cancer	1.03e-05	0.000121	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CG—liver cancer	9.89e-06	0.000116	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PPARG—liver cancer	9.55e-06	0.000112	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—liver cancer	9.25e-06	0.000109	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—HMOX1—liver cancer	9.12e-06	0.000107	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CD—liver cancer	8.7e-06	0.000102	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALB—liver cancer	8.59e-06	0.000101	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—liver cancer	8.5e-06	9.99e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP1A1—liver cancer	8.05e-06	9.47e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CB—liver cancer	7.58e-06	8.92e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—MTHFR—liver cancer	7.51e-06	8.83e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARA—liver cancer	7.37e-06	8.66e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CA—liver cancer	6.83e-06	8.03e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.62e-06	7.78e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CG—liver cancer	6.31e-06	7.42e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPARG—liver cancer	6.09e-06	7.16e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—AKT1—liver cancer	5.58e-06	6.56e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CD—liver cancer	5.55e-06	6.52e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALB—liver cancer	5.47e-06	6.44e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CB—liver cancer	4.83e-06	5.69e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CA—liver cancer	4.62e-06	5.44e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—AKT1—liver cancer	3.78e-06	4.44e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CA—liver cancer	2.95e-06	3.47e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—AKT1—liver cancer	2.41e-06	2.83e-05	CbGpPWpGaD
